Lv1
40 积分 2024-04-14 加入
Flashback Foreword: Gefitinib in Non–Small-Cell Lung Cancer: The IDEAL 1 Trial
1天前
已完结
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
1天前
已完结
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301
1天前
已完结
VP9-2021: ORIENT-31: Phase III study of sintilimab with or without IBI305 plus chemotherapy in patients with EGFR mutated nonsquamous NSCLC who progressed after EGFR-TKI therapy
1年前
已完结
皖公网安备34019202002308
